Avalo Therapeutics, Inc.

NasdaqCM:AVTX Stock Report

Market Cap: US$104.5m

Avalo Therapeutics, Inc. Company Information

Avalo Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Avalo Therapeutics, Inc.
  • Ticker: AVTX
  • Exchange: NasdaqCM
  • Founded: 2011
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$104.532m
  • Shares Outstanding: 10.46m
  • Website: https://www.avalotx.com

Number of Employees

Location

  • Avalo Therapeutics, Inc.
  • 540 Gaither Road
  • Suite 400
  • Rockville
  • Maryland
  • 20850
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AVTXNasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDNov 2015
C6K0DB (Deutsche Boerse AG)YesCommon StockDEEURNov 2015

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/27 23:40
End of Day Share Price 2024/11/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.